Skip to content
HHS Delegates Exclusion Authority to CMS for Healthcare Fraud

HHS Delegates Exclusion Authority to CMS for Healthcare Fraud

First seen 27 Oct 2026, 21:18 UTC • •

Article Content

Browse articles
ThreatCluster AI
ThreatCluster •October 28, 2026 at 01:47 UTC
  • •HHS delegated permissive exclusion authority to CMS effective October 14, 2026.
  • •CMS can now investigate and exclude individuals/entities from federal healthcare programs.
  • •The authority does not include conducting hearings or issuing regulations.

On October 14, 2026, the HHS Office of Inspector General delegated permissive exclusion authority to the CMS, enhancing its ability to investigate healthcare fraud. This delegation allows CMS to exclude individuals and entities from federal healthcare programs, aligning enforcement responsibilities and improving program integrity. HHS Secretary Robert F. Kennedy, Jr. stated that CMS is well-positioned to handle these investigations due to its direct role in administering Medicare and Medicaid. The delegation does not include the authority to conduct hearings or issue regulations, which remains with HHS-OIG. The change is effective immediately, but details on coordination with HHS-OIG and the Department of Justice are still being developed. The delegation is part of ongoing efforts to combat healthcare fraud under the Social Security Act.

Start a free Starter trial for enhanced analysis

Ask AI about this cluster

Updated just now How this analysis works

Timeline

2026-10-14
HHS delegates authority to CMS
HHS formally delegated permissive exclusion authority to CMS to enhance fraud investigations in federal healthcare programs.
Hipaajournal

More articles in this cluster (2)

Common questions

What is the purpose of this delegation?
The delegation aims to improve the investigation and prosecution of healthcare fraud by allowing CMS to exclude individuals and entities from federal healthcare programs.
What does this mean for healthcare providers?
Healthcare providers may face exclusion from federal programs if found to be involved in fraudulent activities, as CMS now has the authority to investigate and impose exclusions.
Are there any immediate changes for affected parties?
While the authority is effective immediately, specific procedures for how CMS will coordinate with HHS-OIG and the Department of Justice are still being developed.